Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement

Launched by LOMA LINDA UNIVERSITY · Aug 25, 2020

Keywords

ClinConnect Summary

This clinical trial is studying ways to reduce radiation exposure during a specific procedure called sacral neuromodulation, which helps treat conditions like overactive bladder and urge incontinence. Participants will be divided into two groups: one will receive standard fluoroscopy settings, while the other will receive experimental settings designed to lower radiation during the procedure. The goal is to see how much radiation each group is exposed to, which can help improve safety for patients undergoing this treatment.

To be eligible for this trial, participants should be between the ages of 65 and 74 and must have issues with urinary urgency, frequency, and nighttime urination, with or without incontinence. However, individuals with certain conditions, like neurogenic bladder or a high body mass index (BMI over 40), cannot participate. If you join the trial, you can expect to receive the same treatment for your overactive bladder, but with a chance to help researchers understand how to make the procedure safer for everyone.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients undergoing lead implantation for sacral neuromodulation that have overactive bladder as defined by urinary urgency, frequency, nocturia with or without urgency incontinence.
• Exclusion Criteria:
• • neurogenic bladder, BMI \>40, or peripheral neuropathy.